Examkin

Soru

Zorluk: OrtaMenstrual Cycle Abnormalities and Contraception

A 29-year-old woman presents to the office due to the absence of menstruation for the past 8 months. She previously had regular 29-day menstrual cycles since menarche at age 12. She reports no recent changes in weight, strenuous exercise habits, nipple discharge, headaches, or visual disturbances. Her past medical history is unremarkable, and she takes no daily medications. She is sexually active with a male partner and uses condoms inconsistently. Vital signs include blood pressure 110/70 mm Hg, pulse 72/min, and BMI 24 kg/m². Physical examination demonstrates normal breast development, appropriate body hair distribution, and a normal appearing cervix and vaginal vault.

Arrange the following diagnostic steps in the most appropriate sequential order for evaluating this patient's secondary amenorrhea.

  1. 1Measurement of serum beta-hCG level
  2. 2Measurement of serum TSH, prolactin, and FSH levels
  3. 3Administration of a progestin withdrawal challenge
  4. 4Administration of sequential estrogen and progestin therapy

Cevap

The correct sequential order for the diagnostic evaluation of secondary amenorrhea is: Measurement of serum beta-hCG level, followed by Measurement of serum TSH, prolactin, and FSH levels, then Administration of a progestin withdrawal challenge, and finally Administration of sequential estrogen and progestin therapy.
The evaluation of secondary amenorrhea follows a rigorous, stepwise algorithm designed to rule out the most common causes first. Because pregnancy is the most frequent cause of secondary amenorrhea in reproductive-aged women, a beta-hCG test is universally the first mandatory step. After excluding pregnancy, the clinician investigates systemic endocrine abnormalities by checking TSH, prolactin, and FSH levels. Elevated prolactin or abnormal TSH indicates a pituitary or thyroid etiology, respectively, while elevated FSH points to primary ovarian insufficiency. If these initial labs are within normal limits, the patient undergoes a progestin withdrawal challenge to determine if she has adequate endogenous estrogen and a patent outflow tract. Withdrawal bleeding confirms anovulation (often due to PCOS) as the underlying cause. If no bleeding occurs, an estrogen-progestin challenge is administered. This final test distinguishes between severe hypoestrogenism (which results in bleeding after exogenous estrogen primes the endometrium) and an anatomical outflow tract obstruction such as Asherman syndrome (which will not bleed despite full hormonal stimulation).

Adım Adım Çözüm

1
Exclude pregnancy.
Measurement of serum beta-hCG level is performed first.
Pregnancy is the leading cause of secondary amenorrhea and must be definitively ruled out before any further diagnostic testing or medication administration, as it alters the interpretation of subsequent hormonal assessments.
2
Evaluate for systemic endocrine causes and primary ovarian failure.
Measurement of serum TSH, prolactin, and FSH levels.
Hypothyroidism and hyperprolactinemia are common, easily reversible causes of amenorrhea. FSH levels help identify primary ovarian insufficiency or functional hypothalamic amenorrhea.
3
Assess endogenous estrogen status and outflow tract patency.
Administration of a progestin withdrawal challenge.
Inducing withdrawal bleeding with a progestin (e.g., medroxyprogesterone acetate) confirms that the patient is producing sufficient baseline estrogen (suggesting anovulation, such as in PCOS) and has an unobstructed outflow tract.
4
Differentiate between outflow tract obstruction and severe hypoestrogenism.
Administration of sequential estrogen and progestin therapy.
If the progestin challenge fails to induce bleeding, providing both estrogen (to proliferate the endometrium) and progestin will cause withdrawal bleeding in patients with severe hypoestrogenism, but will fail to cause bleeding in those with an anatomic abnormality like Asherman syndrome.

Anahtar Kavram

The diagnostic algorithm for secondary amenorrhea requires a stepwise approach, strictly beginning with a pregnancy test, followed by endocrine evaluation, and subsequently challenging the endometrium with hormones if etiology remains unclear.
Bu soruyu puanla

Konular

Menstrual Cycle Abnormalities and Contraception

Bu konudan daha fazla soru